FALL 2003 SEMINAR / PUBLIC LECTURE SERIES

Topics in International Technology Management:
Doing Business With Your Technology in Asia

Laura Mazzola
CEO, Excellin Life Sciences Inc.

Dr. Mazzola has over twelve years of experience in the biotechnology industry, from fundamental research and technology development to the commercialization of integrated instrumentation platforms. She is CEO for Excellin Life Sciences, a start-up with devices for cell engineering. She founded and chairs NanoBioConvergence in the SF Bay Area. Dr. Mazzola was an early employee at Affymax and Affymetrix, developing the high-density array technology that became the prototype for the revolutionary GeneChip(TM) product line. More recently, she helped reorient business development at Symyx Technologies toward the Life Sciences through collaborations with Merck and Eli Lilly and licensed their first commercial product, which won the Frost & Sullivan 2002 Market Engineering Technology Innovation Award.

Dr. Mazzola received a B.S. from Kalamazoo College and a M.S. and Ph.D. from Stanford University.

Back to Fall 2003 Seminars